Mark Howard Snyder
SVP, Chief Legal Officer at Halozyme Therapeutics · 12 reported transactions in 1 company · latest report Feb 23, 2026
Their trades
Shares withheld for tax | Feb 23, 2026 | |||
Exercised options | Feb 23, 2026 | |||
Shares withheld for tax | Feb 20, 2026 | |||
Exercised options | Feb 20, 2026 | |||
Shares withheld for tax | Feb 16, 2026 | |||
Exercised options | Feb 16, 2026 | |||
Shares withheld for tax | Feb 16, 2026 | |||
Exercised options | Feb 16, 2026 | |||
Shares withheld for tax | Jan 3, 2026 | |||
Exercised options | Jan 3, 2026 |